cbdMD, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that cbdMD, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $19.19M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $19.48M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $24.16M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $35.40M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $44.48M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $41.88M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | $23.65M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | $459.1K | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | $4.47M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $2.03M | Dec 26, 2017 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $2.74M | Dec 26, 2017 |
| FY2017 | Sep 30, 2016 | $2.03M | Dec 26, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $11.97M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $12.00M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $14.98M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $22.34M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $29.99M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $26.37M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | $14.51M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | $355.1K | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | $3.12M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $413.1K | Dec 26, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($2.04M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2024 | ($152.8K) | Dec 18, 2024 |
| FY2024 | Jun 30, 2024 | $459.7K | Dec 18, 2024 |
| FY2024 | Mar 31, 2024 | ($3.01M) | Dec 18, 2024 |
| FY2024 | Dec 31, 2023 | ($996.5K) | Dec 18, 2024 |
| FY2024 | Sep 30, 2023 | ($15.87M) | Dec 18, 2024 |
| FY2024 | Jun 30, 2023 | ($1.77M) | Dec 18, 2024 |
| FY2024 | Mar 31, 2023 | ($1.34M) | Dec 18, 2024 |
| FY2024 | Dec 31, 2022 | ($3.96M) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | ($14.63M) | Dec 22, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($2.16M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($3.32M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($22.49M) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | ($78.27M) | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | ($19.62M) | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | ($17.58M) | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | ($14.80M) | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | ($1.80M) | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | ($1.36M) | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | ($3.89M) | Dec 26, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($1.45M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($352.8K) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($4.30M) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | ($14.97M) | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | ($14.09M) | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | ($10.66M) | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | ($15.38M) | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | ($5.57M) | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | ($2.33M) | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | ($2.90M) | Dec 26, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $184.2K | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $190.0K | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $297.5K | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $688.7K | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $342.0K | Dec 15, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $10.42M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $10.58M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $16.20M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $40.79M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $124.88M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $110.84M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | $94.52M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | $15.02M | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | $7.07M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $1.62M | Dec 26, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.19M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $8.62M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $7.16M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $9.37M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $21.74M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $31.66M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | $56.91M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | $998.5K | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | $1.92M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $1.92M | Dec 26, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.23M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.96M | Dec 19, 2025 |
| FY2024 | Jun 30, 2024 | $3.03M | Dec 18, 2024 |
| FY2024 | Mar 31, 2024 | $3.09M | Dec 18, 2024 |
| FY2024 | Dec 31, 2023 | $7.04M | Dec 18, 2024 |
| FY2025 | Sep 30, 2023 | $9.03M | Dec 19, 2025 |
| FY2024 | Jun 30, 2023 | $25.73M | Dec 18, 2024 |
| FY2024 | Mar 31, 2023 | $25.79M | Dec 18, 2024 |
| FY2024 | Dec 31, 2022 | $26.59M | Dec 18, 2024 |
| FY2024 | Sep 30, 2022 | $31.42M | Dec 18, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | $0 | Dec 22, 2023 |
| FY2023 | Sep 30, 2022 | $0 | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $56.67M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $54.67M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | $54.67M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | $0 | Dec 18, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($179.44M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($182.07M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($174.36M) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | ($147.42M) | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | ($73.34M) | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | ($47.39M) | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | ($59.61M) | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | ($6.67M) | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | ($6.26M) | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | ($4.49M) | Dec 26, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.26M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $2.45M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $1.80M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | $6.72M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | $26.41M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | $14.82M | Dec 17, 2021 |
| FY2021 | Sep 30, 2019 | $4.69M | Dec 17, 2021 |
| FY2020 | Sep 30, 2018 | $4.28M | Dec 22, 2020 |
| FY2019 | Sep 30, 2017 | $284.2K | Dec 18, 2019 |
| FY2018 | Sep 30, 2016 | $34.3K | Dec 12, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | (1) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | (14) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | (13) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | (55) | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | (2) | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Dec 18, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | (1) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | (14) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | (13) | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | (55) | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | 0 | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Dec 18, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 8.92M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | 492,383 | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | 2.96M | Dec 18, 2024 |
| FY2023 | Sep 30, 2022 | 1.35M | Dec 22, 2023 |
| FY2022 | Sep 30, 2021 | 57.78M | Dec 15, 2022 |
| FY2021 | Sep 30, 2020 | 52.13M | Dec 17, 2021 |
| FY2020 | Sep 30, 2019 | 27.72M | Dec 22, 2020 |
| FY2019 | Sep 30, 2018 | 8.12M | Dec 18, 2019 |
| FY2018 | Sep 30, 2017 | 5.79M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | 3.40M | Dec 26, 2017 |